Document is current
Any future updates will be listed below
-
Authors
Markousis-Mavrogenis, George https://orcid.org/0000-0001-8192-6670
Baumhove, Lukas https://orcid.org/0000-0002-5860-7943
Al-Mubarak, Ali A. https://orcid.org/0000-0003-3701-8725
Aboumsallem, Joseph Pierre
Bomer, Nils https://orcid.org/0000-0001-5926-6960
Voors, Adriaan A. https://orcid.org/0000-0002-5417-4415
van der Meer, Peter https://orcid.org/0000-0002-9705-4413
- License Information
-
More Information
Article History
Accepted: 3 August 2023
First Online: 14 September 2023
Competing interests
: A.A.V. received consultancy fees and/or research grants from AstraZeneca, Bayer, Boehringer Ingelheim, BMS, Cytokinetics, Merck, Novo Nordisk, Novartis and Roche Diagnostics. P.v.d.M. received consultancy fees and/or grants from Novartis, Corvidia, Singulex, Servier, Vifor Pharma, AstraZeneca, Pfizer and Ionis. The other authors declare no competing interests related to this manuscript.
